177 related articles for article (PubMed ID: 14983226)
21. Matrix metalloproteinases (MMP-2,9) and their tissue inhibitors (TIMP-1,2) as novel markers of stress response and atherogenesis in children with chronic kidney disease (CKD) on conservative treatment.
Musiał K; Zwolińska D
Cell Stress Chaperones; 2011 Jan; 16(1):97-103. PubMed ID: 20821177
[TBL] [Abstract][Full Text] [Related]
22. Metalloproteinase levels are decreased in symptomatic carotid plaques.
Hower CD; Dassow MS; Kajdacsy-Balla A; Seabrook GR; Jean-Claude J; Towne JB; Cambria RA
J Surg Res; 2000 Feb; 88(2):155-9. PubMed ID: 10644482
[TBL] [Abstract][Full Text] [Related]
23. Neutral proteinases and their inhibitors in the loosening of total hip prostheses.
Takagi M
Acta Orthop Scand Suppl; 1996 Oct; 271():3-29. PubMed ID: 8975533
[TBL] [Abstract][Full Text] [Related]
24. Effect of graft reperfusion on intracellular calcium levels in mononuclear leucocytes during human orthotopic liver transplantation.
Enright SM; Srinivasa R; Bellamy MC
Br J Surg; 1998 May; 85(5):673-6. PubMed ID: 9635820
[TBL] [Abstract][Full Text] [Related]
25. Matrix metalloproteinases increase very early during experimental focal cerebral ischemia.
Heo JH; Lucero J; Abumiya T; Koziol JA; Copeland BR; del Zoppo GJ
J Cereb Blood Flow Metab; 1999 Jun; 19(6):624-33. PubMed ID: 10366192
[TBL] [Abstract][Full Text] [Related]
26. Fibrin clot lysis by tissue plasminogen activator (tPA) is impaired in plasma from pediatric patients undergoing orthotopic liver transplantation.
Leaker MT; Brooker LA; Mitchell LG; Weitz JI; Superina R; Andrew ME
Transplantation; 1995 Jul; 60(2):144-7. PubMed ID: 7624956
[TBL] [Abstract][Full Text] [Related]
27. Phase I and pharmacologic study of the specific matrix metalloproteinase inhibitor BAY 12-9566 on a protracted oral daily dosing schedule in patients with solid malignancies.
Rowinsky EK; Humphrey R; Hammond LA; Aylesworth C; Smetzer L; Hidalgo M; Morrow M; Smith L; Garner A; Sorensen JM; Von Hoff DD; Eckhardt SG
J Clin Oncol; 2000 Jan; 18(1):178-86. PubMed ID: 10623708
[TBL] [Abstract][Full Text] [Related]
28. Mediators of fibrinolysis in orthotopic liver transplantation.
Cheema SP; Webster NR; Dunn F; Bellamy MC
Clin Transplant; 1996 Feb; 10(1 Pt 1):24-7. PubMed ID: 8652893
[TBL] [Abstract][Full Text] [Related]
29. Aprotinin reduces the need for blood products during liver transplantation.
Scudamore CH; Randall TE; Jewesson PJ; Shackleton CR; Salvian AJ; Fagan M; Frighetto L; Growe GH; Scarth I; Erb SR
Am J Surg; 1995 May; 169(5):546-9. PubMed ID: 7538269
[TBL] [Abstract][Full Text] [Related]
30. Exercise training reduces systemic inflammation and improves general health status in female migraineurs: a randomised controlled trail.
Pairo Z; Parnow A; Sari Aslani P; Mohammadi P; Mirzaeei S; Mohr M
Eur J Appl Physiol; 2024 May; 124(5):1397-1408. PubMed ID: 38043087
[TBL] [Abstract][Full Text] [Related]
31. Matrix metalloproteinase-9 is increased and correlates with severity in Guillain-Barré syndrome.
Créange A; Sharshar T; Planchenault T; Christov C; Poron F; Raphaël JC; Gherardi RK
Neurology; 1999 Nov; 53(8):1683-91. PubMed ID: 10563613
[TBL] [Abstract][Full Text] [Related]
32. Apoptosis and hepatic allograft reperfusion injury.
Kuo PC; Drachenberg CI; de la Torre A; Bartlett ST; Lim JW; Plotkin JS; Johnson LB
Clin Transplant; 1998 Jun; 12(3):219-23. PubMed ID: 9642513
[TBL] [Abstract][Full Text] [Related]
33. The use of high dose aprotinin in liver transplantation: the influence on fibrinolysis and blood loss.
Grosse H; Lobbes W; Frambach M; von Broen O; Ringe B; Barthels M
Thromb Res; 1991 Aug; 63(3):287-97. PubMed ID: 1720262
[TBL] [Abstract][Full Text] [Related]
34. Coagulation and fibrinolysis in primary biliary cirrhosis compared with other liver disease and during orthotopic liver transplantation.
Segal H; Cottam S; Potter D; Hunt BJ
Hepatology; 1997 Mar; 25(3):683-8. PubMed ID: 9049219
[TBL] [Abstract][Full Text] [Related]
35. Human eosinophils release matrix metalloproteinase-9 on stimulation with TNF-alpha.
Schwingshackl A; Duszyk M; Brown N; Moqbel R
J Allergy Clin Immunol; 1999 Nov; 104(5):983-9. PubMed ID: 10550743
[TBL] [Abstract][Full Text] [Related]
36. Reperfusion damage to the bile canaliculi in transplanted human liver.
Cutrin JC; Cantino D; Biasi F; Chiarpotto E; Salizzoni M; Andorno E; Massano G; Lanfranco G; Rizzetto M; Boveris A; Poli G
Hepatology; 1996 Nov; 24(5):1053-7. PubMed ID: 8903374
[TBL] [Abstract][Full Text] [Related]
37. Tumour necrosis factor-alpha and interleukin-6: early indicators of bacterial infection after human orthotopic liver transplantation.
Sautner T; Függer R; Götzinger P; Mittlböck M; Winkler S; Roth E; Steininger R; Mühlbacher F
Eur J Surg; 1995 Feb; 161(2):97-101. PubMed ID: 7772638
[TBL] [Abstract][Full Text] [Related]
38. Influence of prostaglandin E1 infusion on hemostasis in orthotopic liver transplantation.
Himmelreich G; Hundt K; Bechstein WO; Rossaint R; Neuhaus P; Riess H
Semin Thromb Hemost; 1993; 19(3):273-8. PubMed ID: 7689752
[TBL] [Abstract][Full Text] [Related]
39. Different aprotinin applications influencing hemostatic changes in orthotopic liver transplantation.
Himmelreich G; Muser M; Neuhaus P; Bechstein WO; Slama KJ; Jochum M; Riess H
Transplantation; 1992 Jan; 53(1):132-6. PubMed ID: 1370735
[TBL] [Abstract][Full Text] [Related]
40. The effect of L-arginine and aprotinin on intestinal ischemia-reperfusion injury.
Spanos CP; Papaconstantinou P; Spanos P; Karamouzis M; Lekkas G; Papaconstantinou C
J Gastrointest Surg; 2007 Mar; 11(3):247-55. PubMed ID: 17458594
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
